Association of Physician Certification and Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion.

IF 11.7 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS JACC. Cardiovascular interventions Pub Date : 2024-10-16 DOI:10.1016/j.jcin.2024.10.020
Amit N Vora, Lucy A Pereira, Chengan Du, Zhen Tan, Chien Yu Huang, Daniel J Friedman, Yongfei Wang, Kamil F Faridi, Dhanunjaya R Lakkireddy, Sarah Zimmerman, Angela Y Higgins, Samir R Kapadia, Jeptha P Curtis, James V Freeman
{"title":"Association of Physician Certification and Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion.","authors":"Amit N Vora, Lucy A Pereira, Chengan Du, Zhen Tan, Chien Yu Huang, Daniel J Friedman, Yongfei Wang, Kamil F Faridi, Dhanunjaya R Lakkireddy, Sarah Zimmerman, Angela Y Higgins, Samir R Kapadia, Jeptha P Curtis, James V Freeman","doi":"10.1016/j.jcin.2024.10.020","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Percutaneous left atrial appendage occlusion (LAAO) is indicated in patients with atrial fibrillation for whom long-term oral anticoagulation is contraindicated. Whether outcomes are different based on operator certification [interventional cardiology (IC) versus electrophysiology (EP)] is unclear.</p><p><strong>Objectives: </strong>To compare LAAO outcomes by physician certification (EP versus IC) in the NCDR LAAO Registry.</p><p><strong>Methods: </strong>We identified patients from 2020-2022 undergoing implantation of a Watchman FLX or Amulet LAAO device and stratified patients by primary operator certification. Outcomes of interest included: (1) any major adverse event (MAE), 2) mortality, 3) ischemic stroke, and 4) major bleeding during the initial hospitalization and at 45 days. We performed multivariable Cox proportional hazards regression analysis to determine the risk of adverse events by physician certification.</p><p><strong>Results: </strong>A total of 1,638 physicians (57% electrophysiologists) performing 91,711 procedures during the study period were included. EPs were more likely to use intracardiac echocardiography (25.2% vs 9.7%, p<0.001) and had lower radiation total (235 mGy vs 305 mGy, p<0.001). EPs were more likely than ICs to discharge patients on DOAC+aspirin, whereas ICs were more likely to discharge patients on single or dual antiplatelet therapy (all p<0.001). In-hospital death (0.1% vs. 0.1%, p=0.46) and MAE (1.5% vs 1.6%, p=0.42) were similar by physician certification. At 45 days, there was no difference in death [HR<sub>death</sub> 1.03, 95% CI (0.89-1.2)] or MAE [HR<sub>MAE</sub> 0.97, 95% CI (0.91-1.03)] after multivariable regression.</p><p><strong>Conclusions: </strong>Contemporary LAAO is safe with low rates of procedural complications and no significant differences in procedural outcomes by operator subspecialty after multivariable adjustment. Continued utilization of technology by EPs and ICs is necessary to allow for broad access to this treatment for eligible patients.</p>","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":null,"pages":null},"PeriodicalIF":11.7000,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Cardiovascular interventions","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jcin.2024.10.020","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Percutaneous left atrial appendage occlusion (LAAO) is indicated in patients with atrial fibrillation for whom long-term oral anticoagulation is contraindicated. Whether outcomes are different based on operator certification [interventional cardiology (IC) versus electrophysiology (EP)] is unclear.

Objectives: To compare LAAO outcomes by physician certification (EP versus IC) in the NCDR LAAO Registry.

Methods: We identified patients from 2020-2022 undergoing implantation of a Watchman FLX or Amulet LAAO device and stratified patients by primary operator certification. Outcomes of interest included: (1) any major adverse event (MAE), 2) mortality, 3) ischemic stroke, and 4) major bleeding during the initial hospitalization and at 45 days. We performed multivariable Cox proportional hazards regression analysis to determine the risk of adverse events by physician certification.

Results: A total of 1,638 physicians (57% electrophysiologists) performing 91,711 procedures during the study period were included. EPs were more likely to use intracardiac echocardiography (25.2% vs 9.7%, p<0.001) and had lower radiation total (235 mGy vs 305 mGy, p<0.001). EPs were more likely than ICs to discharge patients on DOAC+aspirin, whereas ICs were more likely to discharge patients on single or dual antiplatelet therapy (all p<0.001). In-hospital death (0.1% vs. 0.1%, p=0.46) and MAE (1.5% vs 1.6%, p=0.42) were similar by physician certification. At 45 days, there was no difference in death [HRdeath 1.03, 95% CI (0.89-1.2)] or MAE [HRMAE 0.97, 95% CI (0.91-1.03)] after multivariable regression.

Conclusions: Contemporary LAAO is safe with low rates of procedural complications and no significant differences in procedural outcomes by operator subspecialty after multivariable adjustment. Continued utilization of technology by EPs and ICs is necessary to allow for broad access to this treatment for eligible patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
左心房阑尾闭塞术患者的医生认证与疗效之间的关系
背景:经皮左心房阑尾封堵术(LAAO)适用于禁忌长期口服抗凝药的心房颤动患者。介入心脏病学(IC)与电生理学(EP)]操作者认证的结果是否不同尚不清楚:比较 NCDR LAAO 注册中不同医师认证(EP 与 IC)的 LAAO 结果:我们确定了 2020-2022 年期间接受 Watchman FLX 或 Amulet LAAO 装置植入的患者,并根据主要操作者认证对患者进行了分层。相关结果包括(1) 任何重大不良事件 (MAE);2) 死亡率;3) 缺血性中风;4) 首次住院期间和 45 天内的大出血。我们进行了多变量考克斯比例危险回归分析,以确定不同医生认证的不良事件风险:在研究期间,共有 1638 名医生(57% 为电生理学家)实施了 91,711 例手术。多变量回归后,电生理学家更有可能使用心内超声心动图(25.2% vs 9.7%,pdeath 1.03,95% CI (0.89-1.2)]或 MAE [HRMAE 0.97,95% CI (0.91-1.03)]:结论:当代 LAAO 是安全的,手术并发症发生率低,经多变量调整后,手术结果与操作者的亚专科无明显差异。为了让符合条件的患者能够广泛接受这种治疗,EP 和 IC 有必要继续利用该技术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
JACC. Cardiovascular interventions
JACC. Cardiovascular interventions CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
11.60
自引率
8.80%
发文量
756
审稿时长
4-8 weeks
期刊介绍: JACC: Cardiovascular Interventions is a specialist journal launched by the Journal of the American College of Cardiology (JACC). It covers the entire field of interventional cardiovascular medicine, including cardiac, peripheral, and cerebrovascular interventions. The journal publishes studies that will impact the practice of interventional cardiovascular medicine, including clinical trials, experimental studies, and in-depth discussions by respected experts. To enhance visual understanding, the journal is published both in print and electronically, utilizing the latest technologies.
期刊最新文献
Editorial Board A Novel Technique for the Common Femoral Artery and its Bifurcation Impact of Severity and Extent of Iliofemoral Atherosclerosis on Clinical Outcomes in Patients Undergoing TAVR The Hostile Score Antithrombotic Therapy in High Bleeding Risk, Part II
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1